Evidence map›Paper›PMID 25819161›Full record

ArticleFree radical biology & medicine2015

Mycobacterium tuberculosis has diminished capacity to counteract redox stress induced by elevated levels of endogenous superoxide.

Priyanka Tyagi, Allimuthu T Dharmaraja, Ashima Bhaskar, Harinath Chakrapani, Amit Singh

Open access · hybridAbstract read
In one paragraph

Article in Free radical biology & medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Host Cell Death and Modulation of Immune Response againstInternational journal of molecular sciences · 2024
    Review
  6. Review
  7. Article
  8. Coevolution ofMicrobiology spectrum · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment.European journal of microbiology & immunology · 2022
    Review
  14. Phenotypic adaptation ofFrontiers in cellular and infection microbiology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Priyanka TyagiDepartment of Microbiology and Cell Biology, Centre for Infectious Disease Research (CIDR), Indian Institute of Science, Bangalore-12, India; International Centre for Genetic Engineering and Biotechnology, New Delhi 67, India.
Allimuthu T DharmarajaDepartment of Chemistry, Indian Institute of Science Education and Research, Pune 08, India.
Ashima BhaskarDepartment of Microbiology and Cell Biology, Centre for Infectious Disease Research (CIDR), Indian Institute of Science, Bangalore-12, India.
Harinath ChakrapaniDepartment of Chemistry, Indian Institute of Science Education and Research, Pune 08, India. Electronic address: harinath@iiserpune.ac.in.
Amit SinghDepartment of Microbiology and Cell Biology, Centre for Infectious Disease Research (CIDR), Indian Institute of Science, Bangalore-12, India. Electronic address: asingh@mcbl.iisc.ernet.in.
Indian Institute of Science Bangalore · INIndian Institute of Science Education and Research Pune · INInternational Centre for Genetic Engineering and Biotechnology · IN

Funding

DBT-Wellcome Trust India Alliance 500034-Z-09-ZWellcome Trust
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) has evolved protective and detoxification mechanisms to maintain cytoplasmic redox balance in response to exogenous oxidative stress encountered inside host phagocytes. In contrast, little is known about the dynamic response of this pathogen to endogenous oxidative stress generated within Mtb. Using a noninvasive and specific biosensor of cytoplasmic redox state of Mtb, we for first time discovered a surprisingly high sensitivity of this pathogen to perturbation in redox homeostasis induced by elevated endogenous reactive oxygen species (ROS). We synthesized a series of hydroquinone-based small molecule ROS generators and found that ATD-3169 permeated mycobacteria to reliably enhance endogenous ROS including superoxide radicals. When Mtb strains including multidrug-resistant (MDR) and extensively drug-resistant (XDR) patient isolates were exposed to this compound, a dose-dependent, long-lasting, and irreversible oxidative shift in intramycobacterial redox potential was detected. Dynamic redox potential measurements revealed that Mtb had diminished capacity to restore cytoplasmic redox balance in comparison with Mycobacterium smegmatis (Msm), a fast growing nonpathogenic mycobacterial species. Accordingly, Mtb strains were extremely susceptible to inhibition by ATD-3169 but not Msm, suggesting a functional linkage between dynamic redox changes and survival. Microarray analysis showed major realignment of pathways involved in redox homeostasis, central metabolism, DNA repair, and cell wall lipid biosynthesis in response to ATD-3169, all consistent with enhanced endogenous ROS contributing to lethality induced by this compound. This work provides empirical evidence that the cytoplasmic redox poise of Mtb is uniquely sensitive to manipulation in steady-state endogenous ROS levels, thus revealing the importance of targeting intramycobacterial redox metabolism for controlling TB infection.

Indexed as

Oxidative StressAntitubercular AgentsBacterial ProteinsClofazimineDNA Repair EnzymesDrug Resistance, BacterialDrug Resistance, Multiple, BacterialGene ExpressionGene Expression Regulation, BacterialGenes, BacterialMicrobial Sensitivity TestsMycobacterium smegmatisMycobacterium tuberculosisOxidation-ReductionSuperoxidesAntitubercular AgentsBacterial ProteinsClofazimineDNA Repair EnzymesSuperoxidesDrug resistanceMycobacterium smegmatisMycobacterium tuberculosisReactive oxygen species (ROS)Redox regulationSuperoxide

Identifiers

PMID25819161
PMCPMC4459714
OpenAlexW292159169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.